STAAR Surgical Company

STAA Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 111.0%, EPS grew 147.1% and free cash flow grew 166.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

21.27 0.99 −4.45%
Market cap
$1.1B
P/E
304×
Fwd P/E
103×
Dividend yield
—
F-score
2/9
Altman Z
6.44
Beneish M
−3.29
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
409.86 0.00 0.00 0.00

+8 more quarters

P/S ratio
4.25 3.21 4.78 5.78
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
73.32 (43.02) (292.42) 500.05
P/B ratio
3.95 2.65 3.33 3.77
Price to Tangible BV
3.97 2.66 3.34 3.79
EV/Sales
3.81 2.76 4.13 4.95
EV/EBITDA
55.79 0.00 0.00 0.00
EV/Operating CF
(397.73) (15.95) (28.91) (38.45)
EV/FCF
(189.32) (14.54) (24.65) (28.80)
Quick Ratio
3.81 4.02 3.47 4.10
Current Ratio
4.66 5.12 4.55 5.21
Net Debt/EBITDA
(13.53) (13.33) 7.54 (9.46)
Debt/Assets
0.00% 6.91% 7.19% 0.00%
Debt/Equity
0.00 0.09 0.09 0.00
Asset Turnover
0.74 0.64 0.50 0.46
Operating CF/Net income
2.44 (4.17) 0.21 0.30
Capex/Depreciation
(0.15) (0.22) (0.74) (0.47)
Research and Development Expense of Revenue
10.63% 10.61% 15.99% 9.72%
Selling, General and Administrative Expense of Revenue
53.12% 44.41% 78.60% 46.68%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
7.01% 5.16% 14.90% 8.61%
Graham Net Nets
0.16 0.23 0.18 0.16
Graham Number
3.38 0.00 0.00 0.00
Earnings Yield
0.24% (2.30%) (7.06%) (7.26%)
Free Cash Flow Yield
(0.47%) (5.90%) (3.51%) (2.97%)
Revenue per Share
1.86 1.87 1.17 1.91
Operating CF per Share
0.39 (0.43) (0.08) 0.05
Capex per Share
(0.01) (0.01) (0.03) (0.02)
Free Cash Flow per Share
0.38 (0.44) (0.11) 0.04
Cash per Share
3.61 3.28 3.78 3.88
Shareholders Equity per Share
7.26 7.06 6.94 7.13
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
7.26 7.06 6.94 7.13
Free Cash Flow
19.20 (22.14) (5.59) 1.78
Working Capital
268.96 251.40 243.04 259.57
Capital Expenditures
(0.49) (0.44) (1.68) (0.88)
Net Current Asset Value
232.55 213.65 204.05 218.63
EV/EBIT
94.19 0.00 0.00 0.00
Capex to Sales
0.01 0.00 0.03 0.01
Price to Operating Income
105.13 0.00 0.00 0.00
Other line items
Average Receivables
66.46 60.56 63.98 82.31
Average Payables
12.91 10.08 14.14 11.94
Average Inventory
49.97 48.96 49.40 46.83
Average Assets
456.49 454.24 480.60 496.98
Average Common Equity
350.99 351.17 370.76 390.95

Fold the line items

Columns are period end dates